YD Bio Limited (NASDAQ: YDES) Launches Nationwide Telehealth Platform for Cancer Detection

March 31, 2026

Expert Analysis YD Bio Limited (NASDAQ: YDES) is making a significant leap forward in the biotechnology space by launching an innovative telehealth platform aimed at enhancing early cancer detection and decentralized clinical services. This strategic move underscores the company’s commitment to leveraging cutting-edge DNA methylation technology for transforming healthcare delivery across the United States. By integrating telehealth capabilities, YD Bio Limited (NASDAQ: YDES) is positioning itself to accelerate the commercialization…

Read More >>